BENEVOLENTAI
LIVE

Serial Number

79255966

Owner

BenevolentAI Limited

Attorney

LEIGH ANN LINDQUIST

Filing Date

Feb 5, 2019

Add to watchlist:

No watchlists yet
View on USPTO

BENEVOLENTAI Trademark

Serial Number: 79255966 • Registration: 6026106

BENEVOLENTAI is a trademark filed by BenevolentAI Limited on February 5, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BenevolentAI Limited (8 trademarks)

4-8 Maple Street

Entity Type: 99

Trademark Details

Filing Date

February 5, 2019

Registration Date

April 7, 2020

Published for Opposition

January 21, 2020

Goods & Services

Library services provided by means of a computerized database; library services, namely, providing electronic library services featuring data stored and retrieved by electronic means; publication of books; publication of journals; publication of electronic books and journals online; publication of material in the nature of electronic books and journals which can be accessed from databases or from the Internet; publication of the results of clinical trials for pharmaceutical preparations in the field of diseases affecting the central nervous system; publication of the results of clinical trials for pharmaceutical preparations

Artificial intelligence apparatus, namely, computer hardware and recorded software for implementing artificial intelligence in products and services; downloadable artificial intelligence software for searching, tracking, exploration and analysis of data for use in the field of healthcare; downloadable artificial intelligence software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines

Pharmaceutical preparations for the treatment of central nervous system [CNS] diseases; pharmaceutical preparations acting on the central nervous system; medicines for the treatment of diseases affecting the central nervous system; medicines for veterinary purposes in the nature of antibiotics; antibiotics for human use; antibiotics for veterinary use; antibiotic food supplements for animals; chemical reagents for medical use; chemical reagents for veterinary use; central nervous system stimulants; nutritional supplements; nutritional supplements for veterinary use; vitamin and mineral supplements; vitamin supplements for animals; veterinary vaccines

Healthcare information, advisory and consultancy services; medical services; medical information, advisory and consultancy services; medical testing for diagnostic or treatment purposes; consulting services in the fields of pharmaceutical research and development; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; consulting and advisory services in the fields of pharmaceutical research and development; veterinary services; veterinary information, advisory and consultancy services; collation of information in the healthcare sector; providing medical information in the healthcare sector; providing medical information concerning pharmaceuticals and the research and development of pharmaceuticals, all of the aforesaid services also provided online via a database or the Internet

Medical instruments for therapeutic drug monitoring; testing apparatus for DNA and RNA testing for medical purposes

Design and development of computer software; providing online non-downloadable computer software for searching, tracking, exploration and analysis of data for use in the field of healthcare; providing online non-downloadable computer software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; Platform as a Service [PaaS], namely, providing artificial intelligence software platforms for searching, tracking, exploration and analysis of data for use in the field of healthcare; Platform as a Service [PaaS], namely, providing artificial intelligence software platforms for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; Software as a Service [SaaS], namely, providing artificial intelligence software for searching, tracking, exploration and analysis of data for use in the field of healthcare; Software as a Service [SaaS], namely, providing artificial intelligence software for searching, tracking, exploration and analysis of data for use in the research and development of pharmaceutical preparations and medicines; hosting of digital content online; hosting of digital content, namely, online journals; computer programming; writing of computer programs for medical applications; writing of computer programs for biotechnological applications; writing of data processing programs; scientific and medical research and development services; scientific research conducted using databases and the Internet; medical research services; pharmaceutical research and development services; pharmaceutical product evaluation; research and development of pharmaceutical preparations and medicines; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; drug discovery services; services for assessing the efficiency of veterinary drugs; services for assessing the efficiency of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of pharmaceutical research and development; information technology consulting services for the pharmaceutical and healthcare industries; providing information about the results of clinical trials for pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information, advisory and consultancy services regarding information technology services for the pharmaceutical and healthcare industries, all of the aforesaid services also provided online via a database or the Internet; providing information, advisory and consultancy services regarding research and development of pharmaceutical preparations and medicines, all of the aforesaid services also provided online via a database or the Internet; providing information and data relating to veterinary research and development, all of the aforesaid services also provided online via a database or the Internet

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 7, 2025 REM3
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 15, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 15, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jul 15, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 15, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 15, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 15, 2022 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 16, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 16, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 16, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 16, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 16, 2022 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 29, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 12, 2020 FICS
FINAL DISPOSITION PROCESSED
Aug 12, 2020 FIMP
NEW REPRESENTATIVE AT IB RECEIVED
Jul 30, 2020 NREP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 7, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 7, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 21, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jan 21, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Jan 17, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 1, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 1, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2020 NONP
ASSIGNED TO LIE
Dec 19, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 18, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 18, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 18, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 18, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 18, 2019 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Dec 18, 2019 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 10, 2019 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 22, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 13, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 12, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 12, 2019 TROA
REFUSAL PROCESSED BY IB
Jun 1, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 11, 2019 RFCS
REFUSAL PROCESSED BY MPU
May 11, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 21, 2019 RFCR
NON-FINAL ACTION WRITTEN
Apr 20, 2019 CNRT
ASSIGNED TO EXAMINER
Apr 17, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 12, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 8, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 4, 2019 REPR